A guidance published Feb. 8 outlines what information FDA needs from manufacturers to evaluate proposed proprietary names to ensure the names do not look or sound like other drug names, which could cause medication errors, according to a Federal Register notice. The 1guidance does not include long-awaited best practices for naming, labeling and packaging drugs or details on a pilot program for evaluating proposed proprietary names, according to the notice. FDA's pilot program to reduce drug name confusion offered firms little reason to participate (2"The Tan Sheet" June 30, 2008). The drug name review process does not apply to monograph drugs but to Rx drugs and OTCs approved through new drug applications, abbreviated NDAs and investigational new drugs
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.
FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
On International Self-Care Day 2025 (July 24) PAGB releases its latest Self-Care Census which finds self-care confidence declining in the UK and AESGP launches a digital platform showcasing national-level self-care initiatives.
Major Europe-based consumer health players Reckitt, Haleon and Bayer feature in this sales and earnings preview, which highlights what to look out for as these three firms report their Q2 2025 results over the coming weeks.